Jin Rong Jie·2025-06-03 10:54Group 1 - The core viewpoint of the articles highlights that Chuangli Medical's stock price closed at 17.19 yuan, with a PE ratio of 51.57, marking a new low in 243 days, and a total market capitalization of 6.594 billion yuan [1] - The average PE ratio for the medical device industry is 50.80, with a median of 36.71, placing Chuangli Medical at the 88th position in the industry ranking [1] - As of the first quarter of 2025, 13 institutions hold shares in Chuangli Medical, including 8 funds, 4 others, and 1 brokerage, with a total holding of 31.6307 million shares valued at 429 million yuan [1] Group 2 - Chuangli Medical specializes in the research, production, and sales of implantable orthopedic medical devices, with key products including spinal, trauma, joint, sports medicine implants, bone repair materials, surgical instruments, PRP preparation kits, and negative pressure drainage kits [1] - The latest performance report for the first quarter of 2025 shows that the company achieved operating revenue of 230 million yuan, a year-on-year increase of 3.60%, and a net profit of 58.0711 million yuan, up 5.20%, with a gross profit margin of 66.69% [1]